Two Infusions, Twelve Weeks: An Experimental Treatment Holds Binge Eating at Bay in Six People

Two Infusions, Twelve Weeks: An Experimental Treatment Holds Binge Eating at Bay in Six People

BioPharmaDispatch reported Entropy Therapeutics' 12-week Cohort 1 results for TRP-8803, an infused psilocin compound: all six patients with treatment-resistant binge eating disorder maintained clinically meaningful improvement, weekly episodes stayed 73% below baseline, and three had no binges at all — very early, small, company-reported data for an unapproved, investigational treatment.

Source

Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends — BioPharmaDispatch, November 2026, reporting Entropy Therapeutics / Swinburne University of Technology

Join the Recovered Life Community here!

What is Recovery News | Mental Health & Addiction Recovery?

Mental Health & Addiction Recovery News.